
Carol H (Hatch) Wysham MD (She/Her)
Diabetes, Lipid Metabolism, Thyroid
Endocrinologist, Rockwood/Multicare Center for Diabetes and Endocrinology
Join to View Full Profile
400 E 5th Ave# 4WSpokane, WA 99202
Phone+1 509-838-2531
Fax+1 509-342-3451
Dr. Wysham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Carol Wysham is an endocrinologist in Spokane, WA and is affiliated with multiple hospitals in the area, including MultiCare Deaconess Hospital and MultiCare Valley Hospital. She received her medical degree from University of Iowa Carver College of Medicine and has been in practice 37 years. She specializes in diabetes, lipid metabolism, and thyroid.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1986
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1980 - 1983
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1980
Certifications & Licensure
OR State Medical License 1982 - Present
WA State Medical License 1992 - 2028
MN State Medical License 1986 - 1993
IA State Medical License 1983 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Centricity EMR, GE Healthcare, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification healthMATRIX, Meridios, Ltd., 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2012, 2014-2017
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
- Two Way Crossover Closed Loop MPC vs Control IQ Start of enrollment: 2023 Mar 13
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsContinuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.Ketan Dhatariya, Richard M Bergenstal, Mohammed Al-Sofiani, Anastasia Albanese-O'Neill, Tadej Battelino
The Lancet. Diabetes & Endocrinology. 2026-01-01 - Preparing to Meet the Needs of a Growing Older Adult Population with Type 1 Diabetes: A Narrative Review.Anna R Kahkoska, Joshua J Neumiller, Anastasia-Stefania Alexopoulos, Antoine Christiaens, Tali Cukierman-Yaffe
Journal of General Internal Medicine. 2025-12-08 - 3 citationsContinuous Glucose Monitoring-Based Titration of Once-Weekly Insulin Icodec in Insulin-Naive Individuals with Type 2 Diabetes (ONWARDS 9): A Phase 3b, Multicenter, Sin...Richard M Bergenstal, Björg Ásbjörnsdóttir, Tanvir Johanning Bari, Satish Hulkund, Yvonne Winhofer
Diabetes Technology & Therapeutics. 2025-07-01
Journal Articles
- Day‐to‐Day Fasting Self‐Monitored Blood Glucose Variability Is Associated with Risk of Hypoglycaemia in Insulin‐Treated Patients with Type 1 and Type 2 Diabetes: A Pos...Gregg Gerety, Anuj Bhargava, Carol H Wysham, Diabetes, Obesity and Metabolism
Lectures
- Insulin Analogs and Diabetes Technology: Past, Present, and FutureENDO 2019 - New Orleans, LA - 3/25/2019
- Master Clinician: Management of Diabetes: Selecting Therapy Based on CVD Outcomes and BeyondENDO 2019 - New Orleans, LA - 3/24/2019
- New Treatments for Type 1 Diabetes and the Pathophysiology of Microvascular ComplicationsENDO 2019 - New Orleans, LA - 3/24/2019
Press Mentions
Preoperative GLP-1RA Use Linked to Lower Postoperative Mortality and Pulmonary RisksMarch 28th, 2025
Abbott’s FreeStyle Libre CGM Systems Now Cleared for Use During Imaging ProceduresOctober 30th, 2024
Abbott CGM Sensors Can Now Be Worn During Common Imaging ProceduresOctober 30th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









